General Information
Starting materials, reagents, and solvents were obtained from commercial sources and used as received.
Progress of the reactions was monitored by thin-layer chromatography (TLC) analysis (Analtech, 0.25 mm silica gel GF254 on glass plates) or by analytical LC-MS using an PelkinElmer AxION 2 TOF MS with UV detection at 214 and 254 nm and an electrospray mode (ESI) coupled with a Flexar/s275/s200EP PDA detector. Purification of intermediates and final products was carried out on normal phase using an ISCO CombiFlash system and prepacked SiO 2 cartridges eluted with optimized gradients of either hexane-ethyl acetate mixture or dichloromethane-methanol as described. Preparative high pressure liquid chromatography (RP-HPLC) was performed on Waters instruments. Systems were run with 5-95% acetonitrile/water gradient with a 0.05% TFA modifier. NMR spectra were recorded on a BrukerAV400 (Avance 400 MHz) instrument. Chemical shifts (δ) are reported in parts per million (ppm) relative to deuterated solvent as the internal standard (CDCl 3 7.26 ppm, DMSO-d 6 2.50 ppm, CD 3 OD 3.31), and coupling constants (J) are in hertz (Hz). Peak multiplicities are expressed as follows: singlet (s), doublet (d), doublet of doublets (dd), triplet (t), quartet (q), multiplet (m), and broad singlet (br s). All final products were characterized by 1 H NMR, 13 C NMR and MS analyses. Except for the known compounds, all new compounds were also characterized and confirmed by HRMS or MALDI-MS.
MALDI-MS data was collected using a Micromass MALDI-R or Voyager DE-Pro operating in reflectron mode. Scheme S1 Synthesis of SAM-Peptide conjugates Compounds 4 and 5 were synthesized according to the procedures we previously reported. [1] Synthesis of compound 6
Synthesis of SAM-Peptide conjugates
2-[(Benzyloxycarbonyl)amino]acetaldehyde (6a) [2, 3] 
S3
To a solution of ethanolamine (2.0 g, 32.8mmol) After the mixture was stirred at room temperature for 1.5 h, a mixture of 2.1 M aqueous Na 2 S 2 O 3 (6 mL) and saturated aqueous NaHCO 3 (6 mL) were added. The organic phase was separated and the aqueous phase was extracted with diethyl ether (3 X 10 mL 
Synthesis of compound 7
To a stirred solution of compound 5 (233 mg, 0.41 mmol, 1.0 eq.) in CH 2 Cl 2 (5 mL) was added into a solution of aldehyde 6a (88 mg, 0.45 mmol, 1.1 eq.) in CH 2 Cl 2 (5 mL) at room temperature. The solution was stirred for 20 min at room temperature. Then sodium triacetoxyborohydride (105 mg, 0.50 mmol, 1.2 eq.) was added in portions and the mixture was stirred at room temperature for 3 h. Saturated aqueous Na 2 CO 3 (10 mL) was added to quench the reaction. The mixture was extracted with CH 2 Cl 2 (2 X 10 mL), dried with anhydrous Na 2 SO 4 , filtered and concentrated in vacuo. The residue was purified by ISCO
S4
CombiFlash system (CH 2 Cl 2 /MeOH, 30:1) to give 7a as a white solid (237 mg, 0.32 mmol, 78% 
5′-N-benzyloxycarbonylaminopropyl-N′-[4-{(2S)-2-(N-tert-butoxycarbonyl)amino-butyric acid}] tert-butyl
ester-5′-deoxy-2′,3′-O,O-(1-methylethylidene)adenosine (7b)
Compound 7b was prepared from 6b as described above. 1 7, 158.8, 158.0, 157.5, 154.0, 150.2, 142.1, 138.5, 129.5, 129.0, 128.8, 120.8, 115.6, 91.8, 86.7, 85.2, 84.8, 82.6, 80.5, 67.4, 57.4, 54.2, 53.1, 52.0, 39.8, 29.8, 28.8, 28.7, 28.4, 28.1, 27.5 
Synthesis of compound 3

5′-N-aminoethyl-N′-[4-{(2S)-2-(N-tert-butoxycarbonyl)amino-butyric acid}] tert-butyl ester-5′-deoxy-2′,3′-
To a solution of compound 7a (420 mg, 0.57 mmol, 1.0 eq.) in methanol (20 mL) was added Palladium on activated charcoal (42 mg, 0.1 eq. w/w). The reaction mixture was degassed under vacuum and then under an atmosphere of H 2 overnight. The reaction mixture was filtered through a short pad of celite. The volatiles were removed to afford 3a (344 mg, 100%). 1 6, 158.4, 157.6, 154.2, 150.3, 142.0, 120.9, 116.3, 92.3, 91.1, 86.3, 85.1, 84.2, 83.0, 80.8, 57.2, 53.5, 53.1, 52.3, 38.8, 30.7, 28.8, 28.4, 27.5, 25.6 
Compound 3b was prepared from 7b as described above. 1 4, 158.3, 157.5, 154.0, 150.3, 142.0, 120.8, 115.9, 93.8, 91.5, 86.1, 85.1, 84.5, 82.9, 80.8, 57.4, 53.9, 53.4, 52.1, 39.8, 29.8, 28.8, 28.3, 27.5, 25.7, 9.3 
S5
Synthesis of compound 1
Peptide synthesis:
The peptides (G*P, G*PKR, G*PPKR, A*PPKR, G*SPKR, A*SPKR, G*PKRIA and G*PRRRS) were synthesized using a Liberty Automated Microwave Peptide Synthesizer (CEM) with the manufacturers standard coupling cycles at 0.1mmol scale. The peptides were synthesized on Rink Amide MBHA resin (Chem Impex) using N-α-Fmoc-protected amino acids (Chem Impex) or α-bromo carboxylic acids (Alfa Aesar).
NAM-C3-GPKR (1a)
To a suspension of G*PKR on resin (0.04 mmol, 1.0 eq.) in DMF (3 mL) was added compound 3b (50 mg, 0.08 mmol, 2.0 eq.) and anhydrous K 2 CO 3 (11 mg, 0.08 mmol, 2.0 eq.). The mixture was shaken at room temperature overnight. The suspension was filtered, and the resin was washed alternatively with 
NAM-C2-GP (1d)
Compound 1d was prepared from 3a and G*P as described above. MALDI-TOF (positive) m/z: calcd for 
